Concepedia

Hyeanjeong Jeong

HJ

Statistics

Publications

4

Citations

100

H-Index

4

Active since

2018

Affiliations

Bio-Medical Science (South Korea)(Current)

Korea University

Korea University of Science and Technology

Korea Institute of Science and Technology

Convergence Research Center for Diagnosis Treatment and Care System of Dementia

Hyeanjeong Jeong is an author at Bio-Medical Science (South Korea) specializing in tau pathology, neurodegenerative disorders, and molecular neurobiology.

Publications per year

2018–2023

4

Publications

4

Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy

Seulgi Shin, Do‐Hee Kim, Ji Yeon Song et al. · Progress in Neurobiology · 2020 · 32 citations · Full text

, , +17

First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent

Ahmed Karam Farag, Ahmed H.E. Hassan, Hyeanjeong Jeong et al. · European Journal of Medicinal Chemistry · 2018 · 31 citations · Full text

, , +9

Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau

Hyeanjeong Jeong, Seulgi Shin, Jun‐Seok Lee et al. · International Journal of Molecular Sciences · 2019 · 23 citations · Full text

, , +17

Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice

Sungsu Lim, Seulgi Shin, Yoonsik Sung et al. · Experimental & Molecular Medicine · 2023 · 14 citations · Full text

, , +17

1–4 of 4